134 related articles for article (PubMed ID: 26935649)
1. Have we had a paradigm change in the treatment of rheumatoid arthritis after the American Congress of Rheumatology 2015?
Bukhari M
Rheumatology (Oxford); 2016 Sep; 55(9):1531-3. PubMed ID: 26935649
[No Abstract] [Full Text] [Related]
2. Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.
Taylor PC; Keystone EC; van der Heijde D; Weinblatt ME; Del Carmen Morales L; Reyes Gonzaga J; Yakushin S; Ishii T; Emoto K; Beattie S; Arora V; Gaich C; Rooney T; Schlichting D; Macias WL; de Bono S; Tanaka Y
N Engl J Med; 2017 Feb; 376(7):652-662. PubMed ID: 28199814
[TBL] [Abstract][Full Text] [Related]
3. Baricitinib (olumiant) for rheumatoid arthritis.
Med Lett Drugs Ther; 2018 Jul; 60(1551):120-121. PubMed ID: 30036348
[No Abstract] [Full Text] [Related]
4. Baricitinib: JAK inhibition for rheumatoid arthritis.
Gras J
Drugs Today (Barc); 2016 Oct; 52(10):543-550. PubMed ID: 27910962
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis.
Nguyen DX; Cotton A; Attipoe L; Ciurtin C; Doré CJ; Ehrenstein MR
J Allergy Clin Immunol; 2018 Sep; 142(3):978-980.e9. PubMed ID: 29935955
[No Abstract] [Full Text] [Related]
6. Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy.
Venerito V; Lopalco G; Anelli MG; Cacciapaglia F; Iannone F
Rheumatology (Oxford); 2019 Mar; 58(3):440. PubMed ID: 30212893
[No Abstract] [Full Text] [Related]
7. Baricitinib in Patients with Refractory Rheumatoid Arthritis.
Genovese MC; Kremer J; Zamani O; Ludivico C; Krogulec M; Xie L; Beattie SD; Koch AE; Cardillo TE; Rooney TP; Macias WL; de Bono S; Schlichting DE; Smolen JS
N Engl J Med; 2016 Mar; 374(13):1243-52. PubMed ID: 27028914
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex infection in a patient with rheumatoid arthritis treated with baricitinib: a case report.
Valor-Méndez L; Voskens C; Rech J; Kleyer A; Schett G
Rheumatology (Oxford); 2021 Apr; 60(4):e122-e123. PubMed ID: 33141876
[No Abstract] [Full Text] [Related]
9. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
10. The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib.
Choy EHS; Miceli-Richard C; González-Gay MA; Sinigaglia L; Schlichting DE; Meszaros G; de la Torre I; Schulze-Koops H
Clin Exp Rheumatol; 2019; 37(4):694-704. PubMed ID: 30767864
[TBL] [Abstract][Full Text] [Related]
11. Baricitinib for the treatment of rheumatoid arthritis.
Kubo S; Nakayamada S; Tanaka Y
Expert Rev Clin Immunol; 2016 Sep; 12(9):911-9. PubMed ID: 27427830
[TBL] [Abstract][Full Text] [Related]
12. Developments with investigational Janus kinase inhibitors for rheumatoid arthritis.
Semerano L; Decker P; Clavel G; Boissier MC
Expert Opin Investig Drugs; 2016 Dec; 25(12):1355-1359. PubMed ID: 27748152
[No Abstract] [Full Text] [Related]
13. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
Deighton CM; George E; Kiely PD; Ledingham J; Luqmani RA; Scott DG
Rheumatology (Oxford); 2006 Jun; 45(6):649-52. PubMed ID: 16527881
[No Abstract] [Full Text] [Related]
14. F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study.
Edupuganti SR; Eder V; Ternant D; Courtehoux M; Tranquart F; Goupille P; Paintaud G; Mulleman D
Joint Bone Spine; 2015 Oct; 82(5):381-3. PubMed ID: 25776440
[No Abstract] [Full Text] [Related]
15. Combination DMARD therapy for rheumatoid arthritis.
Kremer JM
Manag Care; 2001 Jul; 10(7 Suppl):10-4. PubMed ID: 11729428
[No Abstract] [Full Text] [Related]
16. Questioning the Effectiveness of Baricitinib for Pulmonary Manifestations of Rheumatoid Arthritis.
Chertoff J; Ataya A
Am J Respir Crit Care Med; 2017 Nov; 196(10):1353. PubMed ID: 28358994
[No Abstract] [Full Text] [Related]
17. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
Lieberman MR; Liebman TN; Alapati U; Khachemoune A
Dermatol Online J; 2014 Dec; 21(2):. PubMed ID: 25756476
[TBL] [Abstract][Full Text] [Related]
18. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome.
Nousari Y; Wu BC; Valenzuela G
Clin Exp Dermatol; 2021 Oct; 46(7):1330-1332. PubMed ID: 33914946
[No Abstract] [Full Text] [Related]
19. Which TNF inhibitor for rheumatoid arthritis?
Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
[No Abstract] [Full Text] [Related]
20. Adalimumab for rheumatoid arthritis?
Ebell M; Kripke C
Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
